Stage I testicular cancer management and necessity for surgical expertise

Journal of Clinical Oncology

Volumn 26, Issue 18, 2008, Pages 2934-2936

  Sheinfeld, Joel ^a   Motzer, Robert J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DISEASE SEVERITY; EDITORIAL; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; RETROPERITONEAL CANCER; TESTIS CANCER; MALE; NEOPLASM; NOTE; PATHOLOGY; TESTIS TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 46449136066     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.0416     Document Type: Editorial

References (34)

1. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 337:242-253, 1997
2. Vergouwe Y, Steyerberg WE, Eijkemans MJC, et al: Predictors of occult metastasis in clinical stage I nonseminoma: A systematic review. J Clin Oncol 21:4092-4099, 2003
3. Sogani PC, Perrotti M, Herr HW, et al: Clinical stage I testis cancer; Long-term outcome of patients on surveillance. J Urol 159:855-858, 1998
4. Roeleveld TA, Horenblas S, Meinhardt W, et al: Surveillance can be the standard of care of stage I: Nonseminomatous testicular tumors and even high risk patients. J Urol 166:2166-2170, 2001
5. Bohlen D, Borner M, Sonntag RW, et al: Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 161:1148-1152, 1999
6. Cullen MH, Stenning SP, Parkinson MC, et al: Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report. J Clin Oncol 14:1106-1113, 1996
7. Oliver RT, Ong J, Shamash J, et al: Long-term follow-up and Anglian germ cell cancer group surveillance versus patients with stage I nonseminoma treated with adjuvant chemotherapy. Urology 63:556-561, 2004
8. Meinardi MT, Gietema JA, van der Graaf WT, et al: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18:1725-1732, 2000
9. Berger CC, Bokemeyer C, Schneider M, et al: Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Eur J Cancer 31A:2229-2238, 1995
10. Bokemeyer C, Berger CC, Kuczyk MA, et al: Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14:2923-2932, 1996
11. Bajorin DF, Motzer RJ, Rodrigez E, et al: Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst 85:60-62, 1993
12. Huddart RA, Norman A, Shahidi M, et al: Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21:513-1523, 2003
13. Motzer RJ, Bolger GB, Boston B, et al: Testicular cancer. J Natl Comp Canc Netw 4:1038-1058, 2006
14. Albers P, Seiner R, Krege S, et al: Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 26:2966-2972, 2008
15. Jewett MA, Kongt YS, Goldberg SD, et al: Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139:1220-1224, 1988
16. Donohue JP, Foster RS, Rowland RG, et al: Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144:281-292, 1990
17. Whitmore WF Jr: Surgical treatment of adult germinal testis tumors. Semin Oncol 6:55-68, 1979
18. Sheinfeld J: Risks of the uncontrolled retropertineum. Ann Surg Oncol 10:100-101, 2003
19. McKiernan JM, Motzer RJ, Bajorin DF, et al: Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: Clinical presentation, patterns of recurrence, and outcome. Urology 62:732-736, 2003
20. Sheinfeld J, Motzer RJ, Rabbani F, et al: Incidence and clinical outome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. J Urol 170:1159-1162, 2003
21. Foster RS, Baniel J, Leibovitch I, et al: Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retropertioneal teratoma in low stage nonseminomatous testis cancer. J Urol 155:1943-1945, 1996
22. Stephenson AJ, Bosl GJ, Motzer RJ, et al: Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome. J Clin Oncol 23:2781-2788, 2005
23. Donohue JP, Thornhill JA, Foster RS, et al: Retroperitoneal lymphadenectomy for clinical stage A testis (1965 to 1989): Modifications of technique and impact on ejaculation. J Urol 149:237-243, 1993
24. Janetschek G, Reissigl A, Peschel R, et al: Laparascopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular tumor. Urology 44:382-391, 1994
25. Nelson JB, Chen RN, Bishoff JT, et al: Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 54:1064-1067, 1999
26. Sheinfeld J, Herr HW: Role of surgery in management of germ cell tumor. Semin Oncol 25:203-209, 1998
27. Donohue JP, Zachary JM, Maynard BR: Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 128:315-320, 1982
28. Ray B, Hajdu SI, Whitmore WF Jr: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 33:340-348, 1974
29. Weissbach L, Boedefeld EA: Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 138:77-82, 1987
30. Eggener SE, Carver BS, Sharp DS, et al: Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol 177:937-941, 2007
31. Birkmeyer JD, Stukel TA, Siewers AE, et al: Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117-2127, 2003
32. Hu JC, Gold KF, Pashons CL, et al: Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 21:401-405, 2003
33. Heidenreich A, Albers P, Hartmann M, et al: Complications of primary nerve-sparing retroperitoneal lymph node dissection on clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 169:1710-1714
34. Einhorn LH: Testicular cancer as a model for curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 41:3275-3280, 1981